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A 72‐year‐old woman presented to the hospital with right arm edema. She was previously diagnosed as lung adenocarcinoma in the right upper lobe. Her right arm showed pitting edema and purple, painless multiple solitary nodules were found on the right side of her chest (Figure [1](#ccr32331-fig-0001){ref-type="fig"}A). Physical examination and computed tomography findings (Figure [1](#ccr32331-fig-0001){ref-type="fig"}B) revealed cutaneous metastases of lung cancer with superior vena cava (SVC) syndrome. Cutaneous biopsy was attempted, but the procedure was refused by the patient. She was treated with palliative radiation therapy against SVC syndrome, but the effect against edema was scarce.

![A, skin manifestations reveal multiple purple, solitary, and painless nodules suggesting malignancy. B, the image reveals stenosis of the superior vena cava](CCR3-7-1796-g001){#ccr32331-fig-0001}

Reported cases of cutaneous metastases of lung cancer were 1.78% with poor prognosis.[1](#ccr32331-bib-0001){ref-type="ref"} Cutaneous metastases accompanied with lymphangitis carcinomatosa shows various erythemas with upper limb edema,[2](#ccr32331-bib-0002){ref-type="ref"} similar to SVC syndrome which is a major cause of upper limb edema occurring in patients with lung cancer. Systemic chemotherapy is a standard therapy for cutaneous metastases, but is rarely performed due to poor performance status with limited life expectancy. Other than SVC syndrome, clinicians need to keep in mind that cutaneous metastases may account for the radiotherapy‐resistant upper limb edema. Prompt diagnosis with treatment may enable better quality of life for the patient.
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